- Two Lung Masses with Different Responses to Pemetrexed
-
Park KY, Jung JW, Nam SB, Lee HJ, Kim HS, Choi YH, Lee JC
- KMID: 1785681
- Korean J Intern Med.
- 2010 Jun;25(2):213-216.
- doi: 10.3904/kjim.2010.25.2.213
We described here a patient who had two lung masses. Although the two masses had the same histology and a similar good response to initial chemotherapy with gemcitabine and carboplatin,... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapy-Related Acute Megakaryoblastic Leukemia in a Lung Cancer Patient
-
Moon JJ, Nam MH, Lim CS, Lee CK, Cho Y, Yoon SY
- KMID: 1791911
- Ann Lab Med.
- 2014 Mar;34(2):155-158.
- doi: 10.3343/alm.2014.34.2.155
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Progressive Multiple Cystic Changes in Both Lungs in a Patient Treated with Gefitinib for Lung Adenocarcinoma with Multiple Lung Metastases
-
Ryu YJ, Chun EM, Lee SN, Shim SS
- KMID: 1705587
- Korean J Radiol.
- 2014 Apr;15(2):300-304.
- doi: 10.3348/kjr.2014.15.2.300
Gefitinib is regarded as a relatively safe agent for the treatment of an advanced non-small cell lung cancer (NSCLC). Pulmonary toxicity such as interstitial lung disease associated with gefitinib is... -
- CITED
-
- Close
- SHARE
-
- Close
- Secondary Prophylaxis of Docetaxel Induced Diarrhea with Loperamide: Case Report
-
Lee HY, Lee YH, Kim MJ, Kim HK
- KMID: 1777697
- J Korean Med Sci.
- 2013 Oct;28(10):1549-1551.
- doi: 10.3346/jkms.2013.28.10.1549
Diarrhea is a common adverse event of docetaxel with 20%-40% of incidence and severe diarrhea occurs in 5%-6%. Several treatment guidelines for chemotherapy induced diarrhea (CID) exist, however the prophylaxis... -
- CITED
-
- Close
- SHARE
-
- Close
- Vortex Keratopathy in a Patient Receiving Vandetanib for Non-Small Cell Lung Cancer
-
Ahn J, Wee WR, Lee JH, Hyon JY
- KMID: 1098641
- Korean J Ophthalmol.
- 2011 Oct;25(5):355-357.
- doi: 10.3341/kjo.2011.25.5.355
We report a case of vortex keratopathy in a patient treated with vandetanib for non-small cell lung cancer (NSCLC). A 44-year-old female who underwent two cycles of chemotherapy for NSCLC... -
- CITED
-
- Close
- SHARE
-
- Close
- A Phase II Study of Vinorelbine, Mitomycin C and Cisplatin Chemotherapy for Advanced Non-Small Cell Lung Cancer
-
Kwon MR, Jeong TY, Yuh YJ, Kim SR
- KMID: 759617
- Korean J Intern Med.
- 2002 Dec;17(4):240-244.
BACKGROUND: This prospective phase II trial was performed to determine the efficacy and toxicity of mitomycin C, vinorelbine and cisplatin combination chemotherapy for patients with previously untreated stage IIIB... -
- CITED
-
- Close
- SHARE
-
- Close
- Synergistic effect of ERK inhibition on tetrandrine-induced apoptosis in A549 human lung carcinoma cells
-
Cho HS, Chang SH, Chung YS, Shin JY, Park SJ, Lee ES, Hwang SK, Kwon JT, Tehrani AM, Woo M, Noh MS, Hanifah H, Jin H, Xu CX, Cho MH
- KMID: 1089342
- J Vet Sci.
- 2009 Mar;10(1):23-28.
- doi: 10.4142/jvs.2009.10.1.23
Tetrandrine (TET), a bis-benzylisoquinoline alkaloid from the root of Stephania tetrandra, is known to have anti-tumor activity in various malignant neoplasms. However, the precise mechanism by which TET inhibits tumor... -
- CITED
-
- Close
- SHARE
-
- Close
- Weekly Low-Dose Docetaxel for Salvage Chemotherapy in Pretreated Elderly or Poor Performance Status Patients with Non-small Cell Lung Cancer
-
Lee KW, Lim JH, Kim JH, Lee CT, Lee JS
- KMID: 1107523
- J Korean Med Sci.
- 2008 Dec;23(6):992-998.
- doi: 10.3346/jkms.2008.23.6.992
Although docetaxel monotherapy has shown clinical benefits for previously treated patients with advanced non-small cell lung cancer (NSCLC), the efficacy of salvage docetaxel chemotherapy for elderly patients or patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Dendrotoxin-kappa suppresses tumor growth induced by human lung adenocarcinoma A549 cells in nude mice
-
Jang SH, Ryu PD, Lee SY
- KMID: 1067335
- J Vet Sci.
- 2011 Mar;12(1):35-40.
- doi: 10.4142/jvs.2011.12.1.35
Voltage-gated K+ (Kv) channels have been considered to be a regulator of membrane potential and neuronal excitability. Recently, accumulated evidence has indicated that several Kv channel subtypes contribute to the... -
- CITED
-
- Close
- SHARE
-
- Close
- Pulmonary BALT Lymphoma Successfully Treated with Eight Cycles Weekly Rituximab: Report of First Case and F-18 FDG PET/CT Images
-
Bilici A, Seker M, Ustaalioglu BBO, Canpolat N, Salepci T, Gumus M
- KMID: 1777890
- J Korean Med Sci.
- 2011 Apr;26(4):574-576.
- doi: 10.3346/jkms.2011.26.4.574
Extra marginal-zone lymphomas of the lung is a very rare tumor and it originates from bronchial-associated lymphoid tissue. A 68-yr-old woman presented with productive cough and dyspnea. A thorax computed... -
- CITED
-
- Close
- SHARE
-
- Close
- Combinational Treatment with Retinoic Acid Derivatives in Non-small Cell Lung Carcinoma In Vitro
-
Choi EJ, Whang YM, Kim SJ, Kim HJ, Kim YH
- KMID: 1785789
- J Korean Med Sci.
- 2007 Sep;22(Suppl):S52-S60.
- doi: 10.3346/jkms.2007.22.S.S52
The growth inhibitory effects of four retinoic acid (RA) derivatives, 9-cis RA, 13-cis RA, N-(4-hydroxyphenyl) retinamide (4-HPR), and all-trans retinoic acid (ATRA) were compared. In addition, the effects of various... -
- CITED
-
- Close
- SHARE
-
- Close
- Economic Evaluation of Gemcitabine-cisplatin Chemotherapy for Non Small-Cell Lung Cancer Patient in an Outpatient Setting
-
Min SH, Ko SK, Lim JY
- KMID: 1083662
- J Korean Acad Nurs.
- 2008 Jun;38(3):363-371.
- doi: 10.4040/jkan.2008.38.3.363
PURPOSE: This analysis was conducted to evaluate the cost-effectiveness of gemcitabine-cisplatin chemotherapy for non small-cell lung cancer patients in an outpatient setting compared with the traditional inpatient setting. METHODS: A... -
- CITED
-
- Close
- SHARE
-
- Close
- High-Dose Vitamin C Promotes Regression of Multiple Pulmonary Metastases Originating from Hepatocellular Carcinoma
-
Seo MS, Kim JK, Shim JY
- KMID: 2163643
- Yonsei Med J.
- 2015 Sep;56(5):1449-1452.
- doi: 10.3349/ymj.2015.56.5.1449
We report a case of regression of multiple pulmonary metastases, which originated from hepatocellular carcinoma after treatment with intravenous administration of high-dose vitamin C. A 74-year-old woman presented to the... -
- CITED
-
- Close
- SHARE
-
- Close
- A Less Intensive Combination of Paclitaxel and Carboplatin in Advanced Non-small Cell Lung Cancer Patients who Have Aged 60 Years or More and Has a Poor Performance Status
-
Min YJ, Ahn JJ, Noh YJ, Cha HJ, Suh JH, Jung JP, Park CR, Jeong AK, Park JH, Lee KM
- KMID: 759697
- Korean J Intern Med.
- 2004 Jun;19(2):109-113.
BACKGROUND: The aim of this study was to evaluate the response, survival, and toxicities of a less intensive combination of paclitaxel and carboplatin, which is used in advanced non-small cell... -
- CITED
-
- Close
- SHARE
-
- Close
- Transglutaminase 2 Expression Predicts Progression Free Survival in Non-Small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
-
Jeong JH, Cho BC, Shim HS, Kim HR, Lim SM, Kim SK, Chung KY, Islam SM, Song JJ, Kim SY, Kim JH
- KMID: 1777495
- J Korean Med Sci.
- 2013 Jul;28(7):1005-1014.
- doi: 10.3346/jkms.2013.28.7.1005
Transglutaminase 2 (TG2), a cross-linking enzyme, is involved in drug resistance and in the constitutive activation of nuclear factor kappa B (NF-kappaB). We investigated the association of non-small cell lung... -
- CITED
-
- Close
- SHARE
-
- Close
- An important role for peroxiredoxin II in survival of A549 lung cancer cells resistant to gefitinib
-
Kwon T, Rho JK, Lee JC, Park YH, Shin HJ, Cho S, Kang YK, Kim BY, Yoon DY, Yu DY
- KMID: 2155657
- Exp Mol Med.
- 2015 May;47(5):e165.
- doi: 10.1038/emm.2015.24
Redox adaptation is an important concept that explains the mechanisms by which cancer cells survive under persistent endogenous oxidative stress and become resistant to certain anticancer agents. To investigate this... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacogenomic Assessment of Outcomes of Pemetrexed-Treated Patients with Adenocarcinoma of the Lung
-
Jung M, Lee CH, Park HS, Lee JH, Kang YA, Kim SK, Chang J, Kim DJ, Rha SY, Kim JH, Cho BC
- KMID: 2158218
- Yonsei Med J.
- 2013 Jul;54(4):854-864.
- doi: 10.3349/ymj.2013.54.4.854
PURPOSE: The main objective of this study was to evaluate the association between polymorphisms of the target genes of pemetrexed and clinical outcomes in non-small cell lung cancer (NSCLC) patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Potential Antitumor Activity of SIM-89 in Non-Small Cell Lung Cancer Cells
-
Pei J, Chu T, Shao M, Teng J, Sha H, Gu A, Li R, Qian J, Mao W, Li Y, Han B
- KMID: 2419116
- Yonsei Med J.
- 2017 May;58(3):581-591.
- doi: 10.3349/ymj.2017.58.3.581
PURPOSE: c-Met and its ligand, hepatocyte growth factor (HGF), play a critical role in oncogenesis and metastatic progression. The aim of this study was to identify inhibited enzymogram and to... -
- CITED
-
- Close
- SHARE
-
- Close
- Docetaxel Monotherapy as Second-Line Treatment for Pretreated Advanced Non-Small Cell Lung Cancer Patients
-
Ko YH, Lee MA, Hong YS, Lee KS, Park HJ, Yoo IR, Kim YS, Kim YK, Jo KH, Wang YP, Lee KY, Kang JH
- KMID: 1785624
- Korean J Intern Med.
- 2007 Sep;22(3):178-185.
- doi: 10.3904/kjim.2007.22.3.178
BACKGROUND: Second-line chemotherapy offers advanced non-small cell lung cancer (NSCLC) patients a small, but significant increase in survival. Docetaxel is usually administered as a 3-week schedule, yet there is... -
- CITED
-
- Close
- SHARE
-
- Close
- Molecularly Targeted Therapy Using Bevacizumab for Non-Small Cell Lung Cancer: a Pilot Study for the New CT Response Criteria
-
Lee HY, Lee KS, Hwang HS, Lee JW, Ahn MJ, Park K, Kim TS, Yi CA, Chung MJ
- KMID: 1119224
- Korean J Radiol.
- 2010 Dec;11(6):618-626.
- doi: 10.3348/kjr.2010.11.6.618
OBJECTIVE: We wanted to compare the efficacy of the new CT response evaluation criteria for predicting the tumor progression-free survival (PFS) with that of RECIST 1.1 in non-small cell lung... -
- CITED
-
- Close
- SHARE
-
- Close
